| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activation and antiviral effect of acyclovir in cells infected with a varicella-like simian virus
|
Fyfe, James A.
|
|
1982
|
73 |
1P1 |
p. 58-61
4 p.
|
article
|
| 2 |
Acyclovir and vidarabine for the treatment of herpes simplex keratitis
|
Laibson, Peter R.
|
|
1982
|
73 |
1P1 |
p. 281-285
5 p.
|
article
|
| 3 |
Acyclovir and vidarabine monophosphate: Comparison of lontophoretic and intravenous administration for the treatment of HSV-1 stromal keratitis
|
Hill, James M.
|
|
1982
|
73 |
1P1 |
p. 300-304
5 p.
|
article
|
| 4 |
Acyclovir chemistry and spectrum of activity
|
Schaeffer, Howard J.
|
|
1982
|
73 |
1P1 |
p. 4-6
3 p.
|
article
|
| 5 |
Acyclovir clinical pharmacology
|
Lietman, Paul S.
|
|
1982
|
73 |
1P1 |
p. 193-196
4 p.
|
article
|
| 6 |
Acyclovir concentrations and tolerance during repetitive administration for 18 days
|
Laskin, Oscar L.
|
|
1982
|
73 |
1P1 |
p. 221-224
4 p.
|
article
|
| 7 |
Acyclovir in herpes keratitis
|
Collum, Louis M.T.
|
|
1982
|
73 |
1P1 |
p. 290-293
4 p.
|
article
|
| 8 |
Acyclovir inhibition of viral DNA chain elongation in herpes simplex virus-infected cells
|
McGuirt, Paul V.
|
|
1982
|
73 |
1P1 |
p. 67-71
5 p.
|
article
|
| 9 |
Acyclovir in immunocompromised patients with cytomegalovirus disease
|
Balfour Jr., Henry H.
|
|
1982
|
73 |
1P1 |
p. 241-248
8 p.
|
article
|
| 10 |
Acyclovir in mouse cytomegalovirus infections
|
Burns, William H.
|
|
1982
|
73 |
1P1 |
p. 118-124
7 p.
|
article
|
| 11 |
Acyclovir in severe herpes virus infections
|
Van Der Meer, Jos W.M.
|
|
1982
|
73 |
1P1 |
p. 271-274
4 p.
|
article
|
| 12 |
Acyclovir in the treatment of simian varicella virus infection of the African green monkey
|
Soike, Kenneth F.
|
|
1982
|
73 |
1P1 |
p. 112-117
6 p.
|
article
|
| 13 |
Acyclovir tolerance in humans
|
Keeney, Ronald E.
|
|
1982
|
73 |
1P1 |
p. 176-181
6 p.
|
article
|
| 14 |
Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice
|
Collins, Peter
|
|
1982
|
73 |
1P1 |
p. 96-99
4 p.
|
article
|
| 15 |
Acyclovir treatment of experimental genital herpes simplex virus infections
|
Kern, Earl R.
|
|
1982
|
73 |
1P1 |
p. 100-108
9 p.
|
article
|
| 16 |
Acyclovir treatment of experimental herpetic keratitis in the rabbit eye
|
Bauer, D.J.
|
|
1982
|
73 |
1P1 |
p. 109-111
3 p.
|
article
|
| 17 |
Acyclovir treatment of herpes virus infections in immunocompromised humans
|
Alford, Charles A.
|
|
1982
|
73 |
1P1 |
p. 225-228
4 p.
|
article
|
| 18 |
Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1
|
Coen, Donald M.
|
|
1982
|
73 |
1P1 |
p. 351-360
10 p.
|
article
|
| 19 |
Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1
|
O'Brien, William J.
|
|
1982
|
73 |
1P1 |
p. 294-299
6 p.
|
article
|
| 20 |
Clinical evaluation of acyclovir in the treatment of ulcerative herpetic keratitis
|
Shiota, Hiroshi
|
|
1982
|
73 |
1P1 |
p. 307-310
4 p.
|
article
|
| 21 |
Controlled trial of oral acyclovir in the therapy of recurrent herpes simplex genitalis
|
C. Reichman, Richard
|
|
1982
|
73 |
1P1 |
p. 338-341
4 p.
|
article
|
| 22 |
Different in vitro effects of dual combinations of anti-herpes simplex virus compounds
|
Schinazi, Raymond F.
|
|
1982
|
73 |
1P1 |
p. 40-48
9 p.
|
article
|
| 23 |
Disease and latency characteristics of clinical herpes simplex virus isolates after acyclovir therapy
|
Sibrack, Cornelia D.
|
|
1982
|
73 |
1P1 |
p. 372-375
4 p.
|
article
|
| 24 |
Double-blind clinical trial of acyclovir and adenine arabinoside in herpetic corneal ulceration
|
Young, Brendan
|
|
1982
|
73 |
1P1 |
p. 311-312
2 p.
|
article
|
| 25 |
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections
|
Corey, Lawrence
|
|
1982
|
73 |
1P1 |
p. 326-334
9 p.
|
article
|
| 26 |
Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient
|
Schnipper, Lowell E.
|
|
1982
|
73 |
1P1 |
p. 387-392
6 p.
|
article
|
| 27 |
Effectiveness of acycloguanosine and trifluorothymidine as inhibitors of cytomegalovirus infection in vitro
|
Lang, David J.
|
|
1982
|
73 |
1P1 |
p. 49-53
5 p.
|
article
|
| 28 |
Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and l-lysine on latent ganglionic herpes simplex virus in vitro
|
Park, No-Hee
|
|
1982
|
73 |
1P1 |
p. 151-154
4 p.
|
article
|
| 29 |
Effect of acyclovir combined with other antiherpetic agents on varicella zoster virus in vitro
|
Biron, Karen K.
|
|
1982
|
73 |
1P1 |
p. 54-57
4 p.
|
article
|
| 30 |
Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig
|
Landry, Marie L.
|
|
1982
|
73 |
1P1 |
p. 143-150
8 p.
|
article
|
| 31 |
Effect of acyclovir on herpes simplex virus replication in a persistently infected human lymphoblastoid cell line (P3HR-1)
|
Shaw, James E.
|
|
1982
|
73 |
1P1 |
p. 72-76
5 p.
|
article
|
| 32 |
Effect of acyclovir on the deoxyribonucleoside triphosphate pool levels in Vero cells infected with herpes simplex virus type 1
|
Furman, Phillip A.
|
|
1982
|
73 |
1P1 |
p. 14-17
4 p.
|
article
|
| 33 |
Effect of acyclovir on various murine in vivo and in vitro immunologic assay systems
|
Quinn, Richard P.
|
|
1982
|
73 |
1P1 |
p. 62-66
5 p.
|
article
|
| 34 |
Effect of acyclovir treatment on acute and chronic murine cytomegalovirus infection
|
Glasgow, Lowell A.
|
|
1982
|
73 |
1P1 |
p. 132-137
6 p.
|
article
|
| 35 |
Effect of 9-(2-hydroxyethoxymethyl)guanine on viral-specific polypeptide synthesis in human cytomegalovirus-infected cells
|
Mar, Eng-Chun
|
|
1982
|
73 |
1P1 |
p. 82-85
4 p.
|
article
|
| 36 |
Effect of renal failure on the pharmacokinetics of acyclovir
|
Laskin, Oscar L.
|
|
1982
|
73 |
1P1 |
p. 197-201
5 p.
|
article
|
| 37 |
Effects of acyclovir combined with other antiviral agents on human cytomegalovirus
|
Spector, Stephen A.
|
|
1982
|
73 |
1P1 |
p. 36-39
4 p.
|
article
|
| 38 |
Evaluation of the antiherpetic activity of acyclovir in rabbits
|
Trousdale, Melvin D.
|
|
1982
|
73 |
1P1 |
p. 155-160
6 p.
|
article
|
| 39 |
Genetic mechanisms of resistance to acyclovir in herpes simplex virus
|
Crumpacker, Clyde S.
|
|
1982
|
73 |
1P1 |
p. 361-368
8 p.
|
article
|
| 40 |
Human aqueous penetration of topically applied acyclovir ophthalmic ointment, 3 percent
|
Poirier, Robert H
|
|
1982
|
73 |
1P1 |
p. I-
1 p.
|
article
|
| 41 |
Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure
|
Krasny, Harvey C.
|
|
1982
|
73 |
1P1 |
p. 202-204
3 p.
|
article
|
| 42 |
Intravenous acyclovir in genital herpes
|
Mindel, A.
|
|
1982
|
73 |
1P1 |
p. 347-350
4 p.
|
article
|
| 43 |
Introduction: A perspective in drug discovery and development
|
Cuatrecasas, Pedro
|
|
1982
|
73 |
1P1 |
p. 2-3
2 p.
|
article
|
| 44 |
In vitro and in vivo responses of cytomegalovirus to acyclovir
|
Plotkin, Stanley A.
|
|
1982
|
73 |
1P1 |
p. 257-261
5 p.
|
article
|
| 45 |
Isolation and characterization of acyclovir-resistant strains of herpes simplex virus
|
Field, Hugh J.
|
|
1982
|
73 |
1P1 |
p. 369-371
3 p.
|
article
|
| 46 |
Lymphocyte responses to herpes simplex virus isolates from patients with primary and recurrent herpes simplex genitalis
|
Reichman, Richard C.
|
|
1982
|
73 |
1P1 |
p. 86-90
5 p.
|
article
|
| 47 |
Mechanism of action and selectivity of acyclovir
|
Elion, Gertrude B.
|
|
1982
|
73 |
1P1 |
p. 7-13
7 p.
|
article
|
| 48 |
Metabolic disposition of acyclovir in the guinea pig, rabbit, and monkey
|
Good, Steven S.
|
|
1982
|
73 |
1P1 |
p. 91-95
5 p.
|
article
|
| 49 |
Metabolic fate of radioactive acyclovir in humans
|
Miranda, Paulo De
|
|
1982
|
73 |
1P1 |
p. 215-220
6 p.
|
article
|
| 50 |
Mucocutaneous herpes simplex virus infections in immunocompromised patients
|
Whitley, R.
|
|
1982
|
73 |
1P1 |
p. 236-240
5 p.
|
article
|
| 51 |
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host
|
Meyers, Joel D.
|
|
1982
|
73 |
1P1 |
p. 229-235
7 p.
|
article
|
| 52 |
Multicenter trial of acyclovir and trifluorothymidine in herpetic keratitis
|
Lau, C.La
|
|
1982
|
73 |
1P1 |
p. 305-306
2 p.
|
article
|
| 53 |
Neonatal acyclovir pharmacokinetics in patients with herpes virus infections
|
Hintz, Marie
|
|
1982
|
73 |
1P1 |
p. 210-214
5 p.
|
article
|
| 54 |
Optimal treatment of herpes simplex virus encephalitis in mice with oral acyclovir
|
Kern, Earl R.
|
|
1982
|
73 |
1P1 |
p. 125-131
7 p.
|
article
|
| 55 |
Oral acyclovir in the treatment of genital herpes
|
Fiddian, A.Paul
|
|
1982
|
73 |
1P1 |
p. 335-337
3 p.
|
article
|
| 56 |
Overview of acyclovir pharmacokinetic disposition in adults and children
|
Robert Blum, M.
|
|
1982
|
73 |
1P1 |
p. 186-192
7 p.
|
article
|
| 57 |
Patient-initiated therapy for recurrent genital herpetic infections
|
Nahmias, André
|
|
1982
|
73 |
1P1 |
p. 342-346
5 p.
|
article
|
| 58 |
Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses
|
Pagano, Joseph S.
|
|
1982
|
73 |
1P1 |
p. 18-26
9 p.
|
article
|
| 59 |
Pharmacokinetics of acyclovir in humans following intravenous administration
|
Whitley, R.J.
|
|
1982
|
73 |
1P1 |
p. 165-171
7 p.
|
article
|
| 60 |
Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis
|
Van Dyke, Russell B.
|
|
1982
|
73 |
1P1 |
p. 172-175
4 p.
|
article
|
| 61 |
Preclinical toxicology profile of acyclovir: An overview
|
Tucker Jr., Walter E.
|
|
1982
|
73 |
1P1 |
p. 27-30
4 p.
|
article
|
| 62 |
Preface
|
King, Dannie H.
|
|
1982
|
73 |
1P1 |
p. 1-
1 p.
|
article
|
| 63 |
Preliminary studies of acyclovir in chronic hepatitis B
|
Smith, Coleman I.
|
|
1982
|
73 |
1P1 |
p. 267-270
4 p.
|
article
|
| 64 |
Preventive and curative effects of acyclovir on central nervous system infections in hamsters inoculated with herpes simplex virus
|
Van Ekdom, Louis T.S.
|
|
1982
|
73 |
1P1 |
p. 161-164
4 p.
|
article
|
| 65 |
Renal function after acyclovir intravenous injection
|
Brigden, David
|
|
1982
|
73 |
1P1 |
p. 182-185
4 p.
|
article
|
| 66 |
Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir
|
Colby, Brenda M.
|
|
1982
|
73 |
1P1 |
p. 77-81
5 p.
|
article
|
| 67 |
Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus
|
Biron, Karen K.
|
|
1982
|
73 |
1P1 |
p. 383-386
4 p.
|
article
|
| 68 |
Sensitivity of herpes virus isolates from acyclovir clinical trials
|
Collins, Peter
|
|
1982
|
73 |
1P1 |
p. 380-382
3 p.
|
article
|
| 69 |
Species differences in the disposition of acyclovir
|
Miranda, Paulo de
|
|
1982
|
73 |
1P1 |
p. 31-35
5 p.
|
article
|
| 70 |
Spectrum of sensitivity to acyclovir of herpes simplex virus clinical isolates
|
McLaren, Colin
|
|
1982
|
73 |
1P1 |
p. 376-379
4 p.
|
article
|
| 71 |
Therapy of acute herpes zoster with acyclovir in the nonimmunocompromised host
|
Esmann, Viggo
|
|
1982
|
73 |
1P1 |
p. 320-325
6 p.
|
article
|
| 72 |
Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis
|
Spruance, Spotswood L.
|
|
1982
|
73 |
1P1 |
p. 315-319
5 p.
|
article
|
| 73 |
Treatment of cytomegalovirus pneumonia with high-dose acyclovir
|
Wade, James C.
|
|
1982
|
73 |
1P1 |
p. 249-256
8 p.
|
article
|
| 74 |
Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds
|
Klein, Richard J.
|
|
1982
|
73 |
1P1 |
p. 138-142
5 p.
|
article
|
| 75 |
Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous intravenous infusion
|
Spector, Stephen A.
|
|
1982
|
73 |
1P1 |
p. 275-280
6 p.
|
article
|
| 76 |
Treatment of life-threatening Epstein-Barr virus infections with acyclovir
|
Sullivan, John L.
|
|
1982
|
73 |
1P1 |
p. 262-266
5 p.
|
article
|
| 77 |
Treatment of plantar warts with acyclovir
|
Bauer, D.J.
|
|
1982
|
73 |
1P1 |
p. 313-314
2 p.
|
article
|
| 78 |
Use of acyclovir in herpetic ocular infection
|
McGill, James
|
|
1982
|
73 |
1P1 |
p. 286-289
4 p.
|
article
|
| 79 |
Use of acyclovir in premature and term neonates
|
Yeager, Anne S.
|
|
1982
|
73 |
1P1 |
p. 205-209
5 p.
|
article
|
Journal description